Last reviewed · How we verify
C-Cure
At a glance
| Generic name | C-Cure |
|---|---|
| Sponsor | Celyad Oncology SA |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Clinical Evaluation of Short Fiber-Reinforced Composite Restorations With and Without Preheating Approach (NA)
- The Effect of Earplugs on Gag Reflex and Patient Comfort in Root Canal Treatment (NA)
- Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors (PHASE2)
- ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs (PHASE2)
- Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment (PHASE3)
- Performance of Reinforced 3D-Printed Versus Direct Bulk-Filled Resin Composites for Restoring Extensive Class II Cavities in Vital Molars (NA)
- Effects of a Lay-led Anxiety and Depression Self-management Program for Cancer Patients (NA)
- Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- C-Cure CI brief — competitive landscape report
- C-Cure updates RSS · CI watch RSS
- Celyad Oncology SA portfolio CI